olivlawolivlaw

olivLaw · European equity research

Elementis plc ELM.L

United Kingdom · London Stock Exchange · ISIN GB0002418548 · Vertical: Listed companies from United Kingdom

1.94GBP+0.41% · 1 dayClose 05 Nov 2026

Elementis plc is a British maker of specialty additives for formulations, focused on rheology and natural hectorite clay used in cosmetics, personal care and coatings. In fiscal 2025 the company reported Personal Care revenue of $224.5m and Coatings revenue of $373.0m, while weak demand for coatings keeps the focus on innovation and efficiency.

At the close of 05 Nov 2026, Elementis plc (ELM.L) stock was 1.94 GBP (+0.41% on the day), with beta 0.85, 52-week range 1.43–1.94 GBP.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
unavailable
shares as of 31 Dec 2025
P/E (TTM)
unavailable
Diluted EPS TTM -0.08 · TTM to 31 Dec 2025
E/P (TTM)
unavailable
TTM to 31 Dec 2025
Dividend yield
unavailable
Beta (2y)
0.85
Volatility (1y) 24%
52-week range
1.431.94

Price history

Loading chart…

Technical reading

RSI (14)
71.0
overbought (≥ 70)
Bollinger (20, 2)
1.77 – 1.94
above the upper band · %B 1.02 · band width 9.0%
SMA 50 / 200
1.79 / 1.65
uptrend (price > SMA50 > SMA200)
MACD (12, 26, 9)
0.04 / 0.03
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month+7.4%−0.6%+8.1 pp—
3 months+4.0%−4.2%+8.1 pp—
6 months+34.9%+4.3%+30.6 pp—
Year to date+16.9%+7.5%+9.4 pp—
1 year+19.2%+9.9%+9.2 pp+5.8%
3 years+60.1%+49.8%+10.2 pp+26.3%
5 years+38.2%+42.8%−4.6 pp—
Max drawdown (1y)
−18.0%
15 Jan 2026 → 12 May 2026
Max drawdown (5y)
−40.1%
26 Jan 2022 → 29 Sept 2022
Compound annual growth (5y)
+6.7%
EURO STOXX 50 +7.4%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

the price (USD) and the reports are in different currencies

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Fiscal years

Fiscal year202320242025
Revenue713.4 m603.8 m597.5 m
Revenue YoYunavailable−15.4%−1.0%
Net income26.5 m-47.8 m-45.5 m
Net income YoYunavailable−280.4%unavailable
Diluted EPS0.04-0.08-0.08
Diluted EPS YoYunavailable−284.1%unavailable
net %3.7%-7.9%-7.6%
Free cash flow38.7 m83.5 m51.9 m

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
54.6 m USD
Financial debt
236.2 m USD
Net debt
181.6 m USD
Equity
643.9 m USD
Total assets
1.1 bn USD
Debt / equity
0.37x
Current ratio
unavailable
ROE
-6.5%
ROA
-3.8%
FCF margin
8.7%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2023
713.4 m
2024
603.8 m
2025
597.5 m

esef· 07 Apr 2026verified

Cost of revenue
2023
429.1 m
2024
314.2 m
2025
317.4 m

esef· 07 Apr 2026verified

Gross profit
2023
284.3 m
2024
289.6 m
2025
280.1 m

esef· 07 Apr 2026verified

Operating income
2023
58.9 m
2024
96.0 m
2025
109.0 m

esef· 07 Apr 2026verified

Interest expense
2023
21.3 m
2024
22.6 m
2025
19.5 m

esef· 07 Apr 2026verified

Pre-tax income
2023
39.7 m
2024
74.3 m
2025
89.9 m

esef· 07 Apr 2026verified

Income tax
2023
11.5 m
2024
25.5 m
2025
27.6 m

esef· 07 Apr 2026verified

Net income
2023
26.5 m
2024
-47.8 m
2025
-45.5 m

esef· 07 Apr 2026verified

Diluted EPS
2023
0.04
2024
-0.08
2025
-0.08

esef· 07 Apr 2026verified

Dividend per share
2023
0.02
2024
0.03
2025
0.04

esef· 07 Apr 2026derived

Balance sheet · USD

Cash
2023
65.8 m
2024
59.9 m
2025
54.6 m

esef· 07 Apr 2026verified

Receivables
2023
101.8 m
2024
93.3 m
2025
81.6 m

esef· 07 Apr 2026verified

Inventories
2023
163.3 m
2024
152.5 m
2025
142.9 m

esef· 07 Apr 2026verified

Property, plant & equipment, net
2023
423.6 m
2024
338.0 m
2025
—

esef· 15 Apr 2025verified

Total assets
2023
1.5 bn
2024
1.3 bn
2025
1.1 bn

esef· 07 Apr 2026verified

Accounts payable
2023
117.9 m
2024
108.4 m
2025
92.0 m

esef· 07 Apr 2026verified

Short-term debt
2023
—
2024
0
2025
50.0 m

esef· 07 Apr 2026verified

Long-term debt
2023
264.7 m
2024
219.2 m
2025
186.2 m

esef· 07 Apr 2026verified

Current liabilities
2023
158.9 m
2024
131.9 m
2025
164.2 m

esef· 07 Apr 2026verified

Total liabilities
2023
664.1 m
2024
551.4 m
2025
470.7 m

esef· 07 Apr 2026verified

Equity
2023
847.3 m
2024
757.0 m
2025
643.9 m

esef· 07 Apr 2026verified

Shares outstanding at year end
2023
588.9 m
2024
590.1 m
2025
583.3 m

esef· 07 Apr 2026derived

Cash flow · USD

Operating cash flow
2023
76.8 m
2024
100.0 m
2025
74.2 m

esef· 07 Apr 2026verified

Capex
2023
38.1 m
2024
16.5 m
2025
22.3 m

esef· 07 Apr 2026verified

Free cash flow
2023
38.7 m ≈
2024
83.5 m ≈
2025
51.9 m ≈

esef· 07 Apr 2026derived

Investing cash flow
2023
101.1 m
2024
-37.5 m
2025
-7.3 m

esef· 07 Apr 2026verified

Financing cash flow
2023
-168.0 m
2024
-59.8 m
2025
-82.5 m

esef· 07 Apr 2026verified

Dividends paid
2023
0
2024
18.8 m
2025
25.3 m

esef· 07 Apr 2026verified

Share repurchases
2023
—
2024
0
2025
54.1 m

esef· 07 Apr 2026verified

Computed indicators

Growth

Revenue growth (YoY)
-1.0%
computed by olivLawFY 2025
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
13.5%
computed by olivLawFY 2025
Net income growth (YoY)
unavailable
the base of the ratio is not positive
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
unavailable
the base of the ratio is not positive
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
-37.8%
computed by olivLawFY 2025

Profitability

Gross margin
46.9%
computed by olivLawFY 2025
EBITDA margin
unavailable
input data missing
EBIT margin
18.2%
computed by olivLawFY 2025
Net margin
-7.6%
computed by olivLawFY 2025
FCF margin
8.7%
computed by olivLawFY 2025

Returns

ROE
-6.5%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROA
-3.8%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROIC
8.7%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROCE
11.5%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Payout ratio (EPS)
unavailable
insufficient data
Payout ratio (FCF)
48.7%
computed by olivLawFY 2025

Balance sheet

Net debt
181.6 m USD
computed by olivLawbalance sheet at 31 Dec 2025
Net debt / EBITDA
unavailable
input data missing
Debt / equity
0.4x
computed by olivLawbalance sheet at 31 Dec 2025
Interest coverage
5.6x
computed by olivLawFY 2025

Liquidity

Current ratio
unavailable
input data missing
Quick ratio
unavailable
input data missing
Cash ratio
0.3x
computed by olivLawbalance sheet at 31 Dec 2025

Cash

Operating cash flow
74.2 m USD
computed by olivLawFY 2025
Capital expenditure
22.3 m USD
computed by olivLawFY 2025
Free cash flow
51.9 m USD
computed by olivLawFY 2025
FCF conversion
unavailable
insufficient data
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
53 days
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Days inventory outstanding
170 days
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Days payables outstanding
115 days
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Cash conversion cycle
108 days
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025

Market and valuation

Market capitalisation
unavailable
input data missing
Enterprise value
unavailable
input data missing
Market cap / net income TTM
unavailable
input data missing
P/E (TTM)
unavailable
input data missing
Earnings yield
unavailable
input data missing
P/B
unavailable
input data missing
P/S
unavailable
input data missing
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
unavailable
input data missing
P/FCF
unavailable
input data missing
FCF yield
unavailable
input data missing
Dividend yield
unavailable
input data missing
Shareholder yield (distributions)
unavailable
input data missing

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • indicators available: 4 of at least 6
  • score weight coverage: 27.1% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

1.94 GBP

05 Nov 2026Source: olivLaw, closing series

Market cap: unavailable

Price and reporting are in different currencies; market indicators are unavailable.

Key indicators

Market capitalisation
unavailable
input data missing
P/E (TTM)
unavailable
input data missing
P/B
unavailable
input data missing
EV/EBITDA
unavailable
input data missing
ROE
-6.5%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Net margin
-7.6%
computed by olivLawFY 2025
Revenue growth (YoY)
-1.0%
computed by olivLawFY 2025
Dividend yield
unavailable
input data missing

Coverage and freshness

29/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 31 Dec 2025
Latest balance sheet date: 31 Dec 2025
Share count (cover of the latest filing), as of: 31 Dec 2025
Source: esefpublished 07 Apr 2026
verified 88derived 4

Score by group

27% · Insufficient data

Estimated value range

Low
0.57
USD per share
Mid
0.65
USD per share
High
0.77
USD per share
Price: unavailable
Potential to the central value: unavailable (value / price − 1)
Margin of safety: unavailable (1 − price / value)
Agreement between methods: single method · 1 methods used · 1 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 0.57 – 0.77 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)unavailable · input data missing
  • Peers: EV/EBITDAunavailable · input data missing
  • Peers: P/Eunavailable · the base of the ratio is not positive
  • Dividend discount (DDM)0.57 – 0.77 (Mid 0.65)

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Insufficient data

Minimum-evidence gate: indicators available: 4 of at least 6; score weight coverage: 27.1% of at least 60%

FactorValueScoreWeight used
ROIC · Quality8.7%29 (vs peers)38%
Net margin · Quality-7.6%23 (vs peers)23%
FCF conversion · Qualityunavailableunavailable—
Revenue CAGR 3Y · Growthunavailableunavailable—
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheet5.6x63 (on a fixed band)23%
Current ratio · Balance sheetunavailableunavailable—
P/E (TTM) · Valuationunavailableunavailable—
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuationunavailableunavailable—
Shareholder yield (distributions) · Returnsunavailableunavailable—
Payout ratio (FCF) · Returns48.7%100 (on a fixed band)15%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet· partial63/100 · 1/3 factors with a value
  • Growth· partialunavailable · 0/2 factors with a value
  • Quality27/100 · 2/3 factors with a value
  • Returns· partial100/100 · 1/2 factors with a value
  • Valuation· partialunavailable · 0/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

ELEMENTIS PLC (ELM.L). Latest full fiscal year: 2025; data up to 2025-12-31.

Figures computed from the financial statements: revenue 597.5 m USD in 2025; YoY growth -1.0%; net margin -7.6%; ROE -6.5%.

The estimated value range is 0.57–0.77 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (indicators available: 4 of at least 6; score weight coverage: 27.1% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • Payout ratio (FCF): 48.7%

What contradicts it

  • ROIC: 8.7%
  • Net margin: -7.6%

Not assessed (insufficient data or a ratio without meaning): FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Current ratio, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions).

Versus the vertical median

Listed companies from United Kingdom · same country · compared with 39 companies

Multiples and returns vs the median

P/E
—
vertical median 15.3x
EV/EBITDA
—
vertical median —
P/S
—
vertical median 1.5x
P/B
—
vertical median 2.2x
ROE
-6.5%
vertical median 14.4%
below median (−145.2%)
Net margin
-7.6%
vertical median 10.8%
below median (−170.7%)
EBIT margin
18.2%
vertical median 22.9%
below median (−20.5%)
Revenue YoY
-1.0%
vertical median 7.9%
below median (−113.2%)
Net debt/EBITDA
—
vertical median —
Dividend yield
—
vertical median 2.9%

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
BATS.LBritish American Tobacco P.L.C.104.3 bn13.516.5%30.3%−1.0%+7% / +88%
ABF.LAssociated British Foods PLC14.7 bn14.39.2%5.3%−3.1%−5% / −15%
0EV1.LCarnival PLC5.5 bn4.146.7%13.4%+6.4%unavailable / unavailable
BAB.LBabcock International Group PLC5.1 bn24.734.7%4.1%+7.2%−10% / +158%
AUTO.LAutotrader Group PLC4.8 bn16.460.2%47.1%+3.9%−13% / −23%
BBY.LBalfour Beatty PLC4.2 bn16.323.2%2.8%+15.2%+20% / +160%
ABDN.LAberdeen Group PLC4.1 bn10.88.0%28.9%−2.1%+11% / +41%
BKG.LThe Berkeley Group Holdings PLC3.6 bn11.38.8%13.4%−4.2%−0% / −22%
BME.LB&M European Value Retail PLC2.9 bn17.421.2%2.8%+3.7%+68% / −51%
AJB.LAj Bell PLC2.4 bn22.849.9%33.1%+18.0%+8% / +128%
ASHM.LAshmore Group PLC1.4 bn13.913.1%71.6%−0.1%+28% / +18%
BCG.LBaltic Classifieds Group PLC1.2 bn23.215.8%57.6%+6.9%−99% / −99%
APN.LApplied Nutrition PLC763.6 m36.241.2%19.7%+24.2%+71% / unavailable
BAG.LA.G. Barr P.L.C.671.9 m14.414.4%10.8%+4.0%−7% / +26%
ASC.LAsos PLC494.5 m—-81.3%-12.0%−14.7%+71% / +8%
ALFA.LAlfa Financial Software Holdings PLC486.8 m16.361.5%23.8%+15.3%−28% / +10%
AML.LAston Martin Lagonda Global Holdings PLC344.3 m—-93.4%-39.2%−20.6%−45% / −85%
APTD.LAptitude Software Group PLC111.3 m28.57.2%6.2%−7.3%−30% / −23%
AMGO.LAmigo Holdings PLC9.9 m———−81.9%+325% / +844%
ASBE.LAssociated British Engineering PLC605.3 k—-19.1%—unavailableunavailable / unavailable
AMIF.LAmicorp Fs (uk) PLC221.6 k0.127.5%9.1%+8.1%unavailable / unavailable
AAF.LAirtel Africa PLC——24.1%10.6%+29.5%−7% / +164%
AAL.LAnglo American PLC——-19.3%-20.2%+4.5%+30% / +76%
ACG.LAcg Metals Limited——-80.3%-32.0%+134.8%+60% / +63%
AEP.LAnglo-Eastern Plantations PLC——16.1%19.5%+25.0%+5% / +113%

1- and 3-year price returns: for ELM.L from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Scenarios are not available. input data missing

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Elementis plc is a British maker of specialty additives for formulations, focused on rheology and natural hectorite clay used in cosmetics, personal care and coatings. In fiscal 2025 the company reported Personal Care revenue of $224.5m 1 and Coatings revenue of $373.0m 1, while weak demand for coatings keeps the focus on innovation and efficiency.

SWOT

Strengths

  • The company owns a high-grade hectorite mine, a supply advantage that is hard to replicate.
  • Personal Care profitability rose substantially in 2025, showing the effect of cost reduction programmes.
  • The balance sheet is solid, with leverage well within the company's target, giving room for investment and shareholder returns.

Weaknesses

  • Coatings revenue fell in 2025 and depends heavily on construction and industrial demand, which was weak.
  • The Coatings operating margin is lower than that of Personal Care, which limits the profit from each sale.
  • The company relies on a limited number of hectorite-based products, which ties performance to a single natural resource.

Opportunities

  • Rising demand for natural and sustainable ingredients could expand sales of hectorite-based and biobased products.
  • The industry shift to waterborne and powder coatings could open new opportunities for the company's products.
  • Expansion in Asia, where the company has strengthened its capabilities, could support medium-term growth.

Threats

  • Weak demand for industrial and architectural coatings could persist and affect Coatings revenue.
  • Tariffs and currency movements could raise costs or reduce revenue in international operations.
  • Chemical regulation could force costly changes to formulations or production processes.

Risks

  • Weak coatings demandhigh

    If volumes of industrial and architectural coatings stay low, segment revenue and profit could decline further.

  • Tariff exposuremedium

    Tariffs could affect supply costs and competitiveness in international markets, particularly in North America.

  • Currency riskmedium

    Revenue and costs are denominated in several currencies, and a stronger US dollar could reduce results reported in pounds sterling.

  • Dependence on hectoritemedium

    An operational problem at the hectorite mine could disrupt an important sales base in Personal Care and Coatings.

  • Delayed product launcheslow

    If new products such as DEOLUXE SC do not reach commercial sales quickly, planned growth could be postponed.

Investment thesis

What would need to be true (bull case)

  • Personal Care showed solid profit growth, and hectorite-based and innovative products could keep supporting results.
  • The company's own hectorite mine and global presence could give a lasting edge over rivals in specialty additives markets.
  • A solid balance sheet and a policy of returning capital to shareholders could support value for investors over the medium term.

What would break the thesis

  • Coatings fell in 2025, and if construction and industrial demand does not recover, revenue could remain under pressure.
  • Dependence on a limited number of hectorite-based products could make the company vulnerable to demand shifts or supply problems.
  • Tariffs and currency risks could reduce margins in international markets, especially if costs rise faster than prices.

What to watch

  • Trajectory of Coatings revenue and demand for industrial and architectural coatingsQ1 2027
  • Timing of commercial sales of DEOLUXE SC2026
  • Growth pace of hectorite-based and innovation revenue2027
  • Effect of tariffs on supply costs and marginsnext 10-K

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

Elementis develops and sells generic and custom-made formulations to direct customers and distributors. Direct customers account for about two-thirds of revenue and distributors for about one-third 1. The company owns a high-grade hectorite mine, and hectorite is described as a natural alternative to synthetic materials 1. Formulation development can take from 6 months to 3 years, depending on customer requirements 1.

The business model rests on a global structure of plants, R&D centres and offices across four continents, which gives flexible supply and close customer relationships 1. The company invests 2% of revenue in R&D and aims to raise this to 3% over the medium term, with a goal of 20% of revenue from innovation 1. Sales and marketing spend is around 4% of revenue 1.

Capital allocation aims to maximise return on invested capital while keeping the balance sheet strong, with a target dividend payout ratio of 30% 1. In 2025 the company returned about $54m through its first buyback programme, funded by the sale of its Talc business 1.

Segments

Personal Care

Personal Care, covering colour cosmetics, skin care and antiperspirant actives, generated revenue of $224.5m in 2025 with an adjusted operating margin of 32.4% 1. Around 40% of this segment's revenue comes from hectorite-based products, and the launch of DEOLUXE SC, a metal-free antiperspirant, was a key milestone 1.

Coatings

Coatings, covering industrial coatings, architectural coatings and energy, generated revenue of $373.0m in 2025, down on weaker demand, with an adjusted operating margin of 18.9% 1. The energy business, around 10% of this segment, performed strongly 1.

Market context

The personal care and coatings markets are shaped by sustainability, shifting demographics and technological progress 1. The Americas represent 45% of Personal Care revenue 1 and 42% of Coatings revenue 1. Rising demand for natural ingredients could support growth in hectorite-based products 1.

Demand for coatings was weak across regions in 2025, mainly for industrial and architectural coatings 1. If demand for waterborne and powder coatings keeps growing, the company could benefit from its additives portfolio 1.

Trends

  • Sustainability and natural ingredientstailwind

    Consumers increasingly ask for natural ingredients and ethical sourcing, which favours the company's hectorite-based and biobased products 1.

  • Weaker coatings demandheadwind

    Lower volumes of industrial and architectural coatings reduced Coatings revenue in 2025 and could keep weighing on results if construction activity does not recover 1.

  • Shift to waterborne and powder coatingstailwind

    The automotive and marine markets are moving to waterborne and powder coatings, where Elementis has new products such as THIXATROL 5050W 1.

  • Tariffs and supply chain costsmixed

    Tariffs add uncertainty, and the company says it optimises its supply chains to manage changes such as tariffs 1.

Competitive position

Elementis competes in rheology and specialty additives markets with global companies that develop similar formulations for coatings, cosmetics and other industries. According to the annual report, its edge rests on its own natural hectorite, innovation and global reach 1.

Competition centres on innovation, efficiency and pricing, and the company says it defends margins through pricing and cost reduction 1. The supplied sources do not name specific competitors, so the competitive picture cannot be detailed further from these documents 1.

  • Global rheology additive suppliers

    Global additive makers for paints and cosmetics compete with Elementis in the same product categories; the annual report does not name them.

  • Cosmetic ingredient producers

    Personal care ingredient producers compete mainly in the Personal Care segment, where hectorite-based products play an important role.

  • Industrial and architectural coatings additive suppliers

    Specialty coatings additive suppliers compete in the Coatings segment, especially in waterborne formulations.

  • Water-based drilling fluid producers

    In energy, companies offering water-based drilling fluids could be competitors of the Energy business within Coatings.

News & filings

In the press

No news in our archive over the last 180 days.

Annual reports (ESEF)

Sources

  1. [1] Annual report, fiscal year ended 2025-12-31 (ESEF) · SEC / Elementis plc · 31 Dec 2025

Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.